Gainplan’s DermTech, Inc. Common Stock DMTK Stock Holding History

Gainplan’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,001	Closed	-$258K	–	95
2021 Q1	$258K	Buy	+5,001	New	+$262K	0.11%	65

Other funds holding DMTK

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Gainplan's DMTK Position: Q2 2021 in Review

Gainplan sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 5,001 shares — an estimated $258K sold.

Gainplan first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $258K in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

Gainplan reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Gainplan sold 5,001 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $258K.
Gainplan first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Gainplan's DermTech, Inc. Common Stock position peaked at $258K in Q1 2021.
176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Gainplan's 13F filing for Q2 2021, filed 12 Aug 2021.